CME Group Inc.
BG ˙ BUL ˙ US12572Q1058
SecurityBG:MX4A / CME Group Inc.
InstitutionStandard Life Aberdeen plc
Latest Disclosed Ownership611,866 shares
Latest Disclosed Value $ 180,714,624
Standard Life Aberdeen plc reports 1.91% decrease in ownership of MX4A / CME Group Inc.

On April 29, 2026 - Standard Life Aberdeen plc filed a 13F-HR form disclosing ownership of 611,866 shares of CME Group Inc. (BG:MX4A) valued at $180,714,624 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 16, 2026 disclosing 623,766 shares of CME Group Inc.. This represents a change in shares of -1.91% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-04-29 2026-03-31 13F CME GROUP COM 12572Q105 611,866 -11,900 -1.91 180,715 6.09 0.1583
2026-01-16 2025-12-31 13F CME GROUP COM 12572Q105 623,766 1,250 0.20 170,338 0.34 0.1470
2025-11-07 2025-09-30 13F CME GROUP COM 12572Q105 622,516 1,688 0.27 169,769 0.13 0.2685
2025-07-24 2025-06-30 13F CME GROUP COM 12572Q105 620,828 9,594 1.57 169,542 5.57 0.2884
2025-05-13 2025-03-31 13F CME GROUP COM 12572Q105 611,234 -20,287 -3.21 160,602 9.70 0.3132
2025-01-24 2024-12-31 13F CME GROUP COM 12572Q105 631,521 -19,152 -2.94 146,406 2.94 0.2748
2024-10-25 2024-09-30 13F CME GROUP COM 12572Q105 650,673 -9,686 -1.47 142,227 9.55 0.2608
2024-08-09 2024-06-30 13F CME GROUP COM 12572Q105 660,359 -60,292 -8.37 129,827 -16.32 0.2489
2024-05-09 2024-03-31 13F CME GROUP COM 12572Q105 720,651 27,071 3.90 155,149 6.22 0.3042
2024-01-31 2023-12-31 13F CME GROUP COM 12572Q105 693,580 93,713 15.62 146,068 21.62 0.3167
2023-11-07 2023-09-30 13F CME GROUP COM 12572Q105 599,867 -31,830 -5.04 120,105 2.61 0.3065
2024-06-20 2023-06-30 13F/A-1 CME GROUP COM 12572Q105 631,697 -5,062 -0.79 117,047 -4.02 0.2724
2023-08-04 2023-06-30 13F CME GROUP COM 12572Q105 631,697 -5,062 117,047 0.2724
2024-06-20 2023-03-31 13F/A-1 CME GROUP COM 12572Q105 636,759 88,327 16.11 121,952 32.23 0.3052
2023-04-28 2023-03-31 13F CME GROUP COM 12572Q105 636,759 88,327 121,952 0.3052
2024-06-20 2022-12-31 13F/A-1 CME GROUP COM 12572Q105 548,432 -32,532 -5.60 92,224 -10.38 0.2508
2023-02-10 2022-12-31 13F CME GROUP COM 12572Q105 548,432 -32,532 92,224 0.2508
2022-11-10 2022-09-30 13F CME GROUP COM 12572Q105 580,964 43,950 8.18 102,906 -6.21 0.3064
2022-08-05 2022-06-30 13F CME GROUP COM 12572Q105 537,014 2,963 0.55 109,717 -15.64 0.3449
2022-05-04 2022-03-31 13F CME GROUP COM 12572Q105 534,051 -234,948 -30.55 130,060 -25.97 0.3325
2022-02-10 2021-12-31 13F/A-1 CME GROUP COM 12572Q105 768,999 -57,076 -6.91 175,684 8.94 0.3858
2022-02-08 2021-12-31 13F CME GROUP COM 12572Q105 768,999 -57,076 175,684 0.1265
2021-11-15 2021-09-30 13F CME GROUP COM 12572Q105 826,075 9,293 1.14 161,264 -7.17 0.3634
2021-08-10 2021-06-30 13F CME GROUP COM 12572Q105 816,782 72,908 9.80 173,712 14.33 0.3805
2021-05-06 2021-03-31 13F CME GROUP COM 12572Q105 743,874 -287,099 -27.85 151,940 -19.05 0.3454
2021-02-10 2020-12-31 13F CME GROUP COM 12572Q105 1,030,973 -31,525 -2.97 187,689 5.58 0.4574
2020-10-21 2020-09-30 13F CME GROUP COM 12572Q105 1,062,498 -26,738 -2.45 177,766 0.41 0.4744
2020-08-10 2020-06-30 13F CME GROUP COM 12572Q105 1,089,236 76,788 7.58 177,045 1.02 0.4793
2020-05-13 2020-03-31 13F CME GROUP COM 12572Q105 1,012,448 -120,861 -10.66 175,260 -22.96 0.5566
2020-02-18 2019-12-31 13F CME GROUP COM 12572Q105 1,133,309 -356,727 -23.94 227,478 -27.77 0.5497
2019-11-13 2019-09-30 13F CME GROUP COM 12572Q105 1,490,036 -278,371 -15.74 314,919 -8.26 0.7853
2019-08-13 2019-06-30 13F CME GROUP COM 12572Q105 1,768,407 566,581 47.14 343,265 73.54 0.7622
2019-05-14 2019-03-31 13F CME GROUP COM CL A 12572Q105 1,201,826 -255,180 -17.51 197,803 -26.40 0.4286
2019-02-12 2018-12-31 13F CME GROUP COM CL A 12572Q105 1,457,006 -247,005 -14.50 268,745 -7.35 0.6379
2018-11-20 2018-09-30 13F/A-1 CME GROUP COM CL A 12572Q105 1,704,011 -61,918 -3.51 290,057 0.20 0.5406
2018-11-13 2018-09-30 13F CME GROUP COM CL A 12572Q105 1,704,011 -61,918 290,057
2018-08-09 2018-06-30 13F CME GROUP COM CL A 12572Q105 1,765,929 487,442 38.13 289,472 39.99 0.5563
2018-05-15 2018-03-31 13F CME GROUP COM CL A 12572Q105 1,278,487 11,382 0.90 206,783 11.73 0.4101
2018-02-12 2017-12-31 13F CME GROUP COM CL A 12572Q105 1,267,105 -298,440 -19.06 185,079 -12.87 0.3541
2017-11-14 2017-09-30 13F CME GROUP COM CL A 12572Q105 1,565,545 1,565,545 212,413 0.3873
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.